Haemonetics Ownership | Who Owns Haemonetics?

Overview Forecast RevenueFinancials Chart Transcripts

Haemonetics Ownership Summary

Haemonetics is owned by 73.28% institutional investors, 1.18% insiders, and 25.53% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 12.51% of HAE shares. Neuberger Berman Genesis Inv is the top mutual fund, with 4.39% of its assets in Haemonetics shares.

HAE Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Haemonetics	73.28%	1.18%	25.53%
Sector	Healthcare Stocks	42.54%	10.83%	46.63%
Industry	Medical Instruments & Supplies Stocks	40.77%	13.85%	45.38%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	6.02M	12.51%	$293.45M
Blackrock	5.96M	11.73%	$493.00M
Vanguard group	4.83M	10.05%	$235.64M
Neuberger berman group	3.67M	7.63%	$178.87M
State street	1.80M	3.74%	$87.77M
River road asset management	1.65M	3.44%	$80.65M
Ubs group	1.45M	3.02%	$70.80M
Royal bank of canada	1.26M	2.62%	$61.45M
Fmr	1.22M	2.53%	$59.26M
Geode capital management	1.20M	2.50%	$58.66M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Kestrel investment management	101.80K	2.80%	$4.96M
Sio capital management	198.03K	2.44%	$9.65M
North peak capital management	362.37K	1.55%	$17.66M
Expect equity	30.92K	1.47%	$1.51M
Invenomic capital management lp	498.32K	1.18%	$24.29M
Qsv equity investors	20.79K	1.04%	$1.01M
Aristotle capital boston	404.16K	1.02%	$19.70M
River road asset management	1.65M	0.90%	$80.65M
Keene & associates	10.90K	0.68%	$851.38K
Isthmus partners	61.70K	0.67%	$3.01M

Top Buyers

Holder	Shares	% Assets	Change
Ubs group	1.45M	0.01%	582.78K
Invenomic capital management lp	498.32K	1.18%	470.50K
Norges bank	420.12K	0.00%	420.12K
Fmr	1.22M	0.00%	379.98K
North peak capital management	362.37K	1.55%	362.37K

Top Sellers

Holder	Shares	% Assets	Change
Wellington management group llp	317.13K	0.00%	-1.83M
Capital research global investors	-	-	-1.14M
Sg capital management	-	-	-906.89K
Westfield capital management co lp	-	-	-805.92K
Victory capital management	70.99K	0.00%	-707.83K

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	420.12K	0.00%	420.12K	$32.80M
North peak capital management	362.37K	1.55%	362.37K	$17.66M
Assenagon asset management	175.57K	0.01%	175.57K	$8.56M
Arrowstreet capital, limited partnership	126.07K	0.00%	126.07K	$6.14M
Weiss asset management lp	107.66K	0.06%	107.66K	$5.25M

Sold Out

Holder	Change
Colonial trust co / sc	-1.00
Tfc financial management	-1.00
Rfp financial group	-1.00
Tfo-tdc	-2.00
Claris advisors, llc / mo /	-2.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	206	-32.01%	35,258,051	-32.80%	73	0.62%	91	-41.29%	88	-13.73%
Jun 30, 2025	309	-6.93%	54,411,783	0.83%	113	0.98%	158	-12.22%	103	-
Mar 31, 2025	330	-0.30%	53,955,084	-5.19%	107	0.84%	180	4.05%	102	7.37%
Dec 31, 2024	177	-44.51%	31,118,376	-43.80%	61	0.52%	94	-38.16%	49	-56.25%
Sep 30, 2024	317	-2.46%	55,196,535	-1.16%	108	0.90%	152	-9.52%	111	4.72%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Neuberger Berman Genesis Inv	2.11M	4.39%	-80.85K
iShares Core S&P Mid-Cap ETF	1.64M	3.39%	-
Vanguard US Total Market Shares ETF	1.60M	3.19%	1.18K
Vanguard Total Stock Mkt Idx Inv	1.52M	3.16%	-31.96K
iShares Russell 2000 ETF	1.21M	2.52%	-
Vanguard Explorer Inv	1.18M	2.46%	-
Vanguard Small Cap Index	1.17M	2.42%	-7.06K
T. Rowe Price US Smlr Cm Eq A USD	1.06M	2.22%	-54.63K
American Funds SMALLCAP World A	1.01M	2.11%	-374.17K
VA CollegeAmerica Amcap 529A	901.53K	1.79%	-187.69K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Nov 10, 2025	KROLL MARK W	-	Buy	$98.78K
Jul 26, 2024	Strong Stewart W	President, Global Hospital	Sell	$393.04K
Jul 12, 2024	Lingamneni Anila	EVP, Chief Technology Officer	Sell	$7.11K
Jul 11, 2024	Lingamneni Anila	EVP, Chief Technology Officer	Sell	$192.24K
May 29, 2024	Basil Michelle L	EVP and General Counsel	Sell	$362.61K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	1	-
2025 Q3	-	-
2025 Q2	-	-
2024 Q4	-	-
2024 Q3	-	3

HAE Ownership FAQ

Who Owns Haemonetics?

Haemonetics shareholders are primarily institutional investors at 73.28%, followed by 1.18% insiders and 25.54% retail investors. The average institutional ownership in Haemonetics's industry, Medical Instruments & Supplies Stocks, is 40.77%, which Haemonetics exceeds.

Who owns the most shares of Haemonetics?

Haemonetics’s largest shareholders are Blackrock funding, inc. /de (6.02M shares, 12.51%), Blackrock (5.96M shares, 11.73%), and Vanguard group (4.83M shares, 10.05%). Together, they hold 34.30% of Haemonetics’s total shares outstanding.

Does Blackrock own Haemonetics?

Yes, BlackRock owns 11.73% of Haemonetics, totaling 5.96M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 493M$. In the last quarter, BlackRock decreased its holdings by -25.268K shares, a -0.42% change.

Who is Haemonetics’s biggest shareholder by percentage of total assets invested?

Kestrel investment management is Haemonetics’s biggest shareholder by percentage of total assets invested, with 2.80% of its assets in 101.8K Haemonetics shares, valued at 4.96M$.

Who is the top mutual fund holder of Haemonetics shares?

Neuberger Berman Genesis Inv is the top mutual fund holder of Haemonetics shares, with 4.39% of its total shares outstanding invested in 2.11M Haemonetics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools